Netherlands, Utrecht (Utrecht City Campus)

Pharmaceutical Policy Analysis

when 7 July 2014 - 11 July 2014
duration 1 week
fee EUR 1150

Medicines are among the most regulated products in society. From the earliest stages onward, policy makers want to foster the development of safe, effective and affordable medicines for patients. When a drug reaches the market, it is the beginning of a process of complex interactions between patients, prescribers, insurers, pharmaceutical companies and governments. Furthermore, the inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place. This course will give insight into current developments in pharmaceutical policy making and gives a better understanding of the methods available for analysing the effects of policy interventions.

Course leader

Prof. Bert Leufkens, Dr. Richard Laing (WHO), dr. Aukje Mantel-Teeuwisse

Target group

(Post)graduates and professionals within governments, NGOs, industry, universities with a basic knowledge public health/medicine who have an interest in the policy aspects of pharmaceuticals.

Course aim

The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions.

Credits info

Certificate of Attendance

Fee info

EUR 1150: • € 1150 - Course + course materials + housing
• € 950 - Course + course materials

Scholarships

Utrecht Summer School doesn't offer scholarships for this course.

Register for this course
on course website